购物车
- 全部删除
- 您的购物车当前为空
IV-275为BRG1与BRM溴域的抑制剂,能够增强Temozolomide和Bleomycin所诱导的DNA损害。此外,IV-275可抑制GBM(Glioblastoma multiforme)细胞的侵袭性,并增强Temozolomide所诱导的细胞凋亡。
IV-275为BRG1与BRM溴域的抑制剂,能够增强Temozolomide和Bleomycin所诱导的DNA损害。此外,IV-275可抑制GBM(Glioblastoma multiforme)细胞的侵袭性,并增强Temozolomide所诱导的细胞凋亡。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | IV-275 is a dual inhibitor targeting the bromodomains of both BRG1 and BRM. This compound not only augments DNA damage when combined with Temozolomide and Bleomycin but also suppresses the invasiveness of GBM cells. Furthermore, IV-275 amplifies Temozolomide-induced cell death and its apoptosis-inducing activity [1]. |
分子量 | 360.35 |
分子式 | C19H18F2N2O3 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容